1 | 14976230 | 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. | J Pharmacol Exp Ther | 2004 Jun |
1 |
2 | 17318644 | Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice. | Pflugers Arch | 2007 Jul |
1 |
3 | 18477767 | Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization. | J Pharmacol Exp Ther | 2008 Aug |
1 |
4 | 19675284 | Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells. | Am J Physiol Regul Integr Comp Physiol | 2009 Oct |
5 |
5 | 23409098 | Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice. | PLoS One | 2013 |
3 |
6 | 26760532 | Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats. | J Vasc Res | 2015 |
1 |
7 | 28103056 | Age-related changes to vascular protease-activated receptor 2 in metabolic syndrome: a relationship between oxidative stress, receptor expression, and endothelium-dependent vasodilation. | Can J Physiol Pharmacol | 2017 Apr |
1 |
8 | 29709920 | Impairment of Protease-Activated Receptor 2-Induced Relaxation of Aortas of Aged Spontaneously Hypertensive Rat. | Biol Pharm Bull | 2018 |
1 |
9 | 34755491 | Involvement of PAR2 in platelet-derived growth factor receptor-α-positive cell proliferation in the colon of diabetic mice. | Physiol Rep | 2021 Nov |
6 |